Real world evidence

Real World Evidence Solutions Market Outlook: Global Industry Insights, Statistics, Competition & Companies Analysis and Forecasts to 2025

Retrieved on: 
Wednesday, May 8, 2019
Clinical research, Health informatics, Articles, Medical device, Real world evidence

The global Real World Evidence Solutions market 2019 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.

Key Points: 
  • The global Real World Evidence Solutions market 2019 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.
  • This report researches the worldwide Real World Evidence Solutions market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
  • The study objectives of this report are:
    - To analyze global Real World Evidence Solutions status, future forecast, growth opportunity, key market and key players.
  • Real World Evidence Solutions Breakdown Data by Application: Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, Others.

Real World Evidence Solutions Market Outlook: Global Industry Insights, Statistics, Competition & Companies Analysis and Forecasts to 2025

Retrieved on: 
Wednesday, May 8, 2019
Clinical research, Health informatics, Articles, Medical device, Real world evidence

The global Real World Evidence Solutions market 2019 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.

Key Points: 
  • The global Real World Evidence Solutions market 2019 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.
  • This report researches the worldwide Real World Evidence Solutions market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
  • The study objectives of this report are:
    - To analyze global Real World Evidence Solutions status, future forecast, growth opportunity, key market and key players.
  • Real World Evidence Solutions Breakdown Data by Application: Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, Others.

Improving Clinical Trials Efficiency With the Help of Real World Evidence Engagement | A Case Study by Quantzig

Retrieved on: 
Thursday, May 2, 2019
Technology, Data management, Health, Clinical trials, Hospitals, Articles, Health, Clinical research, Business intelligence, Formal sciences, Clinical pharmacology, Real world evidence, Clinical trial, Analytics, Clinical Data, Inc

During the course of this engagement, the real world evidence analytics experts at Quantzig helped a leading healthcare company to improve clinical trials efficiency.

Key Points: 
  • During the course of this engagement, the real world evidence analytics experts at Quantzig helped a leading healthcare company to improve clinical trials efficiency.
  • View the full release here: https://www.businesswire.com/news/home/20190502005606/en/
    Improving clinical trials efficiency with the help of real world evidence engagement.
  • The Solution Offered: Given the complexity of the situation, the experts at Quantzig leveraged real world evidence analytics to understand two critical imperatives cost control and improvements in clinical trials.
  • Quantzig's real world evidence solutions helped the client to:
    Quantzig's real world evidence solutions offered predictive insights on:
    Wondering how to utilize real world data to gain critical insights on treatment plans and ways to improve patient care?

Verantos Announces Collaboration with Amgen on Real World Evidence

Retrieved on: 
Tuesday, March 26, 2019
Articles, Health, Marketing, Amgen, Real world evidence, Life sciences

"Collaborating with Verantos can provide improved insights and solutions to investigate potential treatment options and unmet patient needs."

Key Points: 
  • "Collaborating with Verantos can provide improved insights and solutions to investigate potential treatment options and unmet patient needs."
  • "We appreciate the value Amgen places on innovation in observational research methods and data ascertainment and high accuracy results, and look forward to continuing to support them in real world evidence."
  • Verantos and Amgen plan to submit initial findings from their partnership for peer-reviewed publication in 2019.
  • Achieving credible real-world evidence studies lowers cost and risk in label expansion, post-marketing surveillance, and reimbursement.

Self Care Catalysts and OncologyInformationService Announce Partnership to Generate Patient-centered Insights Into Cancer Treatments in Europe

Retrieved on: 
Thursday, February 14, 2019
Clinical research, Evidence, Health informatics, Health care, Real world evidence, Real world data, Self-care

Self Care Catalysts (SCC) and the OncologyInformationService (O.I.s)) are announcing a partnership to develop a patient-centered, real world dataset to drive advancements in cancer research.

Key Points: 
  • Self Care Catalysts (SCC) and the OncologyInformationService (O.I.s)) are announcing a partnership to develop a patient-centered, real world dataset to drive advancements in cancer research.
  • The partnership will generate new insights by combining clinical Real World Data (RWD) with patient experience data to establish Real World Evidence (RWE) from across Europe.
  • Self Care Catalysts Advisor and Oncologist, Ethan Basch, MD, has shown that the mere act of having a patient self-report on their care improves outcomes.
  • O.I.s) and Self Care Catalysts both are rapidly emerging as the most trusted brands in patient-centered cancer research."

COTA, Inc. to Showcase the Importance of Real-World Evidence at HIMSS19

Retrieved on: 
Monday, February 4, 2019
Articles, Health, Health informatics, Evidence-based medicine, Precision medicine, Systems biology, Point of care, Real world evidence

This organized and de-identified patient data now has the ability to provide deep and accurate real-world clinical evidence in real-time, allowing for the ability to make a difference at the point of care.

Key Points: 
  • This organized and de-identified patient data now has the ability to provide deep and accurate real-world clinical evidence in real-time, allowing for the ability to make a difference at the point of care.
  • "We're excited to be attending HIMSS19 this year to discuss how the application of RWE can enable precision medicine at scale in oncology care.
  • Founded by oncologists and data scientists, COTA, Inc. builds solutions that analyze real-world evidence and deliver clinically relevant insights to improve cancer care.
  • To learn more about COTA and how to make better healthcare decisions with the right data, visit cotahealthcare.com.

Real World Evidence Analytics: Enhancing Commercial Spend Effectiveness and Launch Forecasts by 50% | Quantzig

Retrieved on: 
Thursday, January 31, 2019
Health, Medical devices, Pharmaceutical, General Health, Health, Clinical research, Business intelligence, Formal sciences, Medical statistics, Analytics, Big data, Clinical trial, Real world evidence, Pharmacovigilance, Prescriptive analytics

View the full release here: https://www.businesswire.com/news/home/20190131005620/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20190131005620/en/
    REAL WORLD EVIDENCE ANALYTICS STUDY FOR A HEALTHCARE SERVICES PROVIDER.
  • However, if real world evidence analytics is applied systematically, it would help businesses save billions across different segments in the healthcare industry.
  • Quantzig's real world evidence analytics studies helped the client to:
    Categorize drug and medical device safety risks accurately.
  • Quantzig's real world evidence analytics studies offered predictive insights on:
    Identifying long-term adverse drug effects, leading to better decisions about future clinical trials.

Pharmaceutical and Life Sciences Real World Evidence: Market Landscape and Competitive Insights, 2018-2030

Retrieved on: 
Wednesday, January 16, 2019
Health, Clinical research, Evidence, Public health, Real world evidence, Pharmaceutical industry

Real world evidence has demonstrated the potential to validate the therapeutic value of pharmaceutical products and help customize product development in a more patient centric manner.

Key Points: 
  • Real world evidence has demonstrated the potential to validate the therapeutic value of pharmaceutical products and help customize product development in a more patient centric manner.
  • In fact, it is estimated that, on an average, a big pharmaceutical company spends nearly USD 20 million annually for generating real world evidence-based insights.
  • The 'Pharmaceutical and Life Sciences Real World Evidence: Market Landscape and Competitive Insights, 2018-2030' report features an extensive study on the industry players that are offering real world data / analytics / services to the pharmaceutical and life sciences industries.
  • The real world evidence solutions market is expected to grow at an annualized rate of 14.1% between 2018 and 2030.

2018 Report: Real World Evidence Has Demonstrated the Potential to Validate the Therapeutic Value of Pharmaceutical Products and Help Customize Product Development in a More Patient Centric Manner

Retrieved on: 
Tuesday, November 20, 2018
Clinical research, Evidence, Public health, Real world evidence

Close to 200 players are actively involved in providing real-world evidence-based insights into the pharmaceutical industry.

Key Points: 
  • Close to 200 players are actively involved in providing real-world evidence-based insights into the pharmaceutical industry.
  • Of these, around 45% offer a range of services for real-world evidence generation.
  • The real world evidence solutions market is expected to grow at an annualized rate of 14.1% between 2018 and 2030.
  • This is followed by Asia-Pacific and the rest of the world, which currently captures around 10% of the overall market share.

New Best Practices, LLC Study Examines Real World Evidence Trends and Vendor Selection in Pharmaceutical Industry

Retrieved on: 
Friday, August 31, 2018
Economy, Business, RWE, Real world evidence, Outsourcing

CHAPEL HILL, N.C., Aug. 31, 2018 /PRNewswire/ --Recognizing the increased complexity in evidence demands for pharmaceutical products after launch, pharmaceutical companies are boosting their internal Real World Evidence (RWE) capabilities.

Key Points: 
  • CHAPEL HILL, N.C., Aug. 31, 2018 /PRNewswire/ --Recognizing the increased complexity in evidence demands for pharmaceutical products after launch, pharmaceutical companies are boosting their internal Real World Evidence (RWE) capabilities.
  • Best Practices, LLC recently conducted a new study that not only informs on market trends related to RWE generation utilization but also examines the vendor traits that make for the best RWE outsourcing partner.
  • For this research study, Best Practices, LLC engaged a total of 25 pharmaceutical leaders in 19 companies involved with RWE generation.
  • The study, which contains more than 1,000 metrics, has chapters devoted to these issues and RWE study methods:
    Overview of RWE Study Methods Utilization, Data Collection Methods & Outsourcing